Amgen (AMGN) PT Raised to $243 at Goldman Sachs After AMG 510 Lung Cancer Response Rate Data Appears In-Line
Tweet Send to a Friend
Goldman Sachs analyst Terence Flynn raised the price target on Amgen (NASDAQ: AMGN) to $243.00 (from $229.00) after 8 investigators ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
